 |
| Introduction |  Top |
|
 |
|
One drug does not fit all p1
Andrew Marshall
doi:10.1038/5133
PDF
(174K)
|
|
| Commentaries | Top |
|
|
|
Why pharmacogenomics? Why now? pp2 - 3
David Housman
& Fred D. Ledley
doi:10.1038/5134
References | PDF
(178K)
|
|
|
|
Pharmacogenetics and drug metabolism pp4 - 5
Simon Ball
& Neil Borman
doi:10.1038/5135
References | PDF
(531K)
|
|
| Features | Top |
|
|
|
Laying the foundations for personalized medicines pp6 - 8
Andrew Marshall
doi:10.1038/5138
References | PDF
(259K)
|
|
|
|
Getting the right drug into the right patient pp9 - 12
Andrew Marshall
doi:10.1038/5141
References | PDF
(375K)
|
|
|
|
Pharmacogenomics: Will the regulators approve? pp13 - 15
John Hodgson
& Andrew Marshall
doi:10.1038/5143
References | PDF
(219K)
|
|
|
|
Genetic variation in drug development pp16 - 19
doi:10.1038/5147
Abstract | PDF
(244K)
|
|
| Resources | Top |
|
|
|
Pharmacogenomics and diagnostics pp20 - 21
Aris Persidis
doi:10.1038/5153
References | PDF
(178K)
|
|
|
Top |
|
|
